HealthTech Leader NeuroSense Interviewed on CNN About AI in Diagnosis

Eight minutes on the limits of diagnostic AI, from a spokesperson willing to say what the technology cannot yet do.

Why this story landed

Reporters at CNN were already tracking the category. What they did not have was a company willing to put numbers and a named executive behind a claim the rest of the market was hedging on. That is the whole trade: specificity in exchange for attention.

The brief we worked from had three constraints, and every draft was measured against them:

• A single verifiable claim carrying the lead paragraph.
• An executive cleared to speak on the record for five straight days.
• No adjective that a competitor could have written about themselves.

Inside the placement

We pitched on a Tuesday against a Thursday embargo, which gave the desk two clear days to verify the figures with a third party rather than taking the release at face value. Verified numbers survive the edit; unverified ones get cut to a single hedged sentence.

The release we sent was the fourth draft. The first three were things we wanted to be true. The fourth was the part we could prove.

— Dev Patel, Director of Media Relations, PRCOM

What happened next

Within seventy-two hours the story had been picked up by four secondary outlets, two of which had previously declined the same pitch without the anchor coverage attached. Inbound from analysts tripled against the prior month, and the piece is still the first result for HealthTech on the query that matters most to the sales team.

How we would run it again

Earlier spokesperson prep, and one more week of runway before the embargo. Everything else — the sequencing, the exclusive, the follow-on outreach — held up.